Rehabilitation Research
FDA Clearance of the Myomo e100 NeuroRobotic System
Published in Medical Letter on the CDC and FDA, July 29th, 2007
Myomo Inc. announced that the company received U.S. Food and Drug Administration (FDA) 510(k) clearance to market the Myomo e100 NeuroRobotic™ System. Myomo’s first product is a wearable, portable therapeutic modality designed to allow patients to self initiate and control movement of partially paralyzed limbs using their own biological signals. By simultaneously engaging and reinforcing both neurological and motor pathways, the device helps people relearn how to move affected muscles. No electrical stimulation or invasive procedures are employed.
Relearning how to move hemiparetic arms after stroke is a significant challenge. Stroke is the country’s leading cause of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Asthma
Can an apple a day keep asthma away? - Plague
Generation Boomeritis: Here’s How to Dodge the Aches and Injuries That Can Plague - Prostate Cancer
FDA finds no strong link between tomatoes and reduced cancer risk - Type 2 Diabetes
Class of medications may offer alternative option for treating type 2 diabetes - U.S. Centers for Disease Control and Prevention
Few Children Walk or Bike Even Short Distances to School - Allergies
FDA Advice: What You Need to Know About Food Allergies - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
